title: [Aspirin resistance in patients with stable ischemic heart disease].
authors.forename: P S
authors.initials: PS
authors.lastname: Laguta
authors.forename: O V
authors.initials: OV
authors.lastname: Katkova
authors.forename: A B
authors.initials: AB
authors.lastname: Dobrovol'skiĭ
authors.forename: E V
authors.initials: EV
authors.lastname: Titaeva
authors.forename: A D
authors.initials: AD
authors.lastname: Deev
authors.forename: E P
authors.initials: EP
authors.lastname: Panchenko
mesh_terms: D000368:Aged; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D017023:Coronary Angiography; D016903:Drug Monitoring; D004351:Drug Resistance; D017548:Echocardiography, Transesophageal; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism* / Q000503:physiopathology; D010972:Platelet Activating Factor / Q000378:metabolism*; D012307:Risk Factors; D012720:Severity of Illness Index; D013929:Thromboxane B2 / Q000031:analogs & derivatives* / Q000652:urine; D016896:Treatment Outcome
chemical_list: D010972:Platelet Activating Factor; D013929:Thromboxane B2; C049235:11-dehydro-thromboxane B2; D001241:Aspirin